News
Esperion Therapeutics has agreed to acquire Corstasis Therapeutics in a deal worth up to US$255m, adding a nasal spray treatment for heart failure-related fluid retention to its portfolio. Under the agreement, Esperion will pay US$75m in upfront cash for all outstanding Corstasis shares. Shareholders may also receive up to US$180m in additional payments linked to [...]
The NHS is the most trusted organisation for responsible AI use in the UK, according to a survey of citizens and public sector workers. The findings come from the 2026 UK Public Sector AI Adoption Outlook, conducted by Censuswide on behalf of software firm Appian, which surveyed 1,000 UK public sector workers and 1,000 UK [...]
Alcidion today announces that Miya Precision Concept Detection has been included on the Australian Register of Therapeutic Goods (ARTG – #522634) as a Class 1 Medical Device. The capability has also been successfully registered as a Class 1 Medical Device with the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom. Concept Detection [...]
By Sanius Health Gene therapy has now moved decisively from scientific ambition to clinical reality, and in doing so, it has redefined what is possible for patients living with severe genetic conditions such as sickle cell disease, where curative intent is no longer a distant aspiration but a regulated, deployable therapeutic pathway. What we are [...]
By John Romano, co-founder & chief strategy Officer, Gifthealth For pharmacists, a daily challenge is not just dispensing medication – it is managing the complex, often chaotic, journey of patients with gastrointestinal (GI) diseases. More than 60 million people in the US are affected by digestive diseases. Yet many patients struggle to effectively access life-changing [...]
Munich-based Noxon has secured seed funding to advance its muscle-computer interface, a wearable technology designed to monitor and stimulate muscles during therapy. The medtech startup, founded in 2022 as a spin-off from three universities, is developing a device that combines continuous muscle monitoring with neuromuscular electrical stimulation (NMES). NMES is a therapy that uses small [...]
ChatGPT Health regularly fails to identify when users need urgent medical attention and frequently misses signs of suicidal ideation, according to a study that experts warn could "feasibly lead to unnecessary harm and death." As reported by The Guardian, OpenAI launched the Health feature of ChatGPT to limited audiences in January, marketing it as a [...]
A new daily pill could offer a more effective oral GLP-1 option for weight loss, according to a clinical trial that may open the door to an improved non-injection alternative to Wegovy and Mounjaro. The drug, orforglipron, manufactured by Eli Lilly and prescribed for type 2 diabetes, targets the same GLP-1 receptors as oral semaglutide. [...]
German digital health startup Oska Health has raised €11 million in seed funding to expand its hybrid care model for patients living with chronic conditions. The round was led by Capricorn Partners and SwissHealth Ventures, with contributions from Revent, Calm Storm, LBBW Venture Capital, BMH, GoHub Ventures and Aurum Impact. The company combines trained health [...]
People living with dementia will help close a long-standing weakness in research - the clinical trial evidence gap - in a new home-based study. While those over 65 account for two-thirds of illness in the UK, they make up just one-third of trial participants. This "participation gap" means many life-saving drugs are tested on populations [...]
